Chemical SOP
Microbiology SOP
Warehouse SOP
Manufacturing SOP
Information technology SOP

Risk Assessment for Electricity Failure in Pharma

Risk Assessment for Electricity Failure in Pharma

Post Views: 3,544 Introduction: Electricity is a critical utility in pharmaceutical manufacturing facilities, research laboratories, and quality control environments. It powers essential systems, including production machinery, HVAC (Heating, Ventilation, and Air Conditioning), cleanroom environmental controls, critical storage units, water purification…

Risk Assessment of using Expired Filter Bags

Risk Assessment for using Expired Filter Bags

Post Views: 242 Introduction: Filter bags are critical components used in various manufacturing processes to remove particulate matter, ensure product purity, and maintain process sterility or cleanliness. Each filter bag has a defined shelf life, determined by the manufacturer, based…

Risk Assessment for Batch Release before QC Release

Risk Assessment for Batch Release before QC Release

Post Views: 443 Batch Release Before QC Release (sometimes called conditional, provisional, or preliminary release) is the process of approving a batch for distribution before all final Quality Control test results (e.g., assay, microbiology, stability) are available. 1️⃣ Definition This…

Risk Assessment for Guidelines not followed

Risk Assessment for Guidelines not followed

Post Views: 93 Pharmaceutical guidelines are structured recommendations and requirements established to ensure that medicinal products are consistently produced, controlled, and distributed to the highest standards of quality, safety, and efficacy. These guidelines are critical because medicines directly impact human…

Risk Assessment for Cross Contamination in Microbiology

Risk Assessment for Cross-Contamination in Microbiology

Post Views: 246 Cross Contamination in microbiology refers to the unintentional transfer of microorganisms from one material, sample, culture, environment, or person to another. This process can occur through various routes, including direct contact, airborne dispersal, or via contaminated instruments…

Risk Assessment for White Precipitates observed in Vial

Risk Assessment for White Precipitates observed in Vial

Post Views: 76 The presence of White precipitates in parenteral vials is a critical deviation from the expected appearance of the drug product. Such precipitates can arise from a range of underlying factors including formulation instability, inadequate solubility of active…

error: Content is protected !!

This is the Premium Content

You can access this page after paying the subscription fees of 21 ₹ /month only.